Home » Topics » Disease categories and therapies » Endocrine/metabolic

Endocrine/metabolic
RSS

Third submission for Muse

Nov. 8, 1996

Treatment guidelines for erectile dysfunction

Nov. 8, 1996

Little time devoted to treating male infertility in U.S.

Nov. 8, 1996

Scotia clarifies questions regarding its PLA dossier for Tarabetic

Nov. 8, 1996

Novo Nordisk/Takeda diabetes collaboration

Nov. 8, 1996

Phase IIb/IIc trials with CholestaGel

Nov. 8, 1996

Federal Circuit affirms patent judgment for Amgen against Genetics Institute

Nov. 8, 1996

Squalene synthase inhibitors reported by RPR

Nov. 8, 1996

Yamanouchi discloses hypocholesterolemic agents

Nov. 8, 1996

NPS and SKB extend osteoporosis research collaboration

Nov. 8, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 24, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 24, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
HIV research is close to a cure but far from ending the pandemic
BioWorld
Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...
ADEL wins $1.04B Sanofi deal for tau-targeting Alzheimer’s drug
BioWorld
ADEL Inc. closed a year-end licensing deal worth up to $1.04 billion with Sanofi SA for ADEL-Y01, a specific tau-targeting Alzheimer’s disease drug candidate in a...